research Performance Evaluation of the Generative Pre-trained Transformer (GPT-4) on the Family Medicine In-Training Examination Read Performance Evaluation of the Generative Pre-trained Transformer (GPT-4) on the Family Medicine In-Training Examination
post President’s Message: ABFM’s Unwavering Commitment to Diplomates and the Specialty Read President’s Message: ABFM’s Unwavering Commitment to Diplomates and the Specialty
post “Family Medicine Was All I Ever Wanted to Do” Dr. Phillip Wagner Read “Family Medicine Was All I Ever Wanted to Do”
Longitudinal Assessment Content Outline Category Percent Total Cardiovascular 12% 36 Endocrine 8% 24 Gastrointestinal 7% 21 Hematologic/Immune 3% 9 Integumentary 6% 18 Musculoskeletal 12% 36 Nephrologic 3% 9 Neurologic 3% 9 Nonspecific 9% 27 Psychogenic 7% 21 Reproductive - Female 4% 12 Reproductive - Male 1% 3 Respiratory 13% 39 Special Sensory 2% 6 Population-based Care This includes topics such as biostatistics and epidemiology, evidence-based medicine, prevention, health policy and legal issues, bioterror, quality improvement, and geographic/urban/rural issues. 5% 15 Patient-based Systems This includes topics such as clinical decision-making, communication and doctor-patient interaction, family and cultural issues, ethics, palliative care, and end-of-life care. 5% 15 Total 300
Category Percent Total Cardiovascular 12% 36 Endocrine 8% 24 Gastrointestinal 7% 21 Hematologic/Immune 3% 9 Integumentary 6% 18 Musculoskeletal 12% 36 Nephrologic 3% 9 Neurologic 3% 9 Nonspecific 9% 27 Psychogenic 7% 21 Reproductive - Female 4% 12 Reproductive - Male 1% 3 Respiratory 13% 39 Special Sensory 2% 6 Population-based Care This includes topics such as biostatistics and epidemiology, evidence-based medicine, prevention, health policy and legal issues, bioterror, quality improvement, and geographic/urban/rural issues. 5% 15 Patient-based Systems This includes topics such as clinical decision-making, communication and doctor-patient interaction, family and cultural issues, ethics, palliative care, and end-of-life care. 5% 15 Total 300
